Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain
Status:
Active, not recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to see if optimized use of naproxen for treatment of dysmenorrhea
will improve pain report from baseline. In addition, we will determine whether cross-organ
influences from the uterus on bladder pain sensitivity change from baseline after reduced
menstrual pain experience over six months. Finally, a battery of quantitative sensory tests
and EEG measures of sensory sensitivity will be used to evaluate mechanisms associated with
improvements in menstrual and bladder pain.